Clinical Trial Update: TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT [NA]

View source ↗

Summary

A clinical trial is evaluating a combination of transarterial chemoembolization (TACE) with atezolizumab/bevacizumab and I-125 seed brachytherapy for hepatocell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Tumor Thrombosis

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion | NA | Status: RECRUITING